Ticker Symbol: PHAT
Phathom Pharmaceuticals Inc
$21.23 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001783183
Company Profile
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders.
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.phathompharma.com
CEO: N/A
Tags:
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Medicinal and Botanical Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $10.09
Change:
-$0.06
(
-0.59%)
Days Range: $9.78 - $10.14
Beta: 1.46
52wk. High: $17.02
52wk. Low: $5.84
Ytd. Change -10.13%
50 Day Moving Average: $11.17
200 Day Moving Average: $12.40
Shares Outstanding: 56803183
Valuation
Market Cap: 57.3B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A